Cargando…
Formalin fixation for optimal concordance of programmed death‐ligand 1 immunostaining between cytologic and histologic specimens from patients with non–small cell lung cancer
BACKGROUND: Immunohistochemical staining of programmed death‐ligand 1 (PD‐L1) is used to determine which patients with non–small cell lung cancer (NSCLC) may benefit most from immunotherapy. Therapeutic management of many patients with NSCLC is based on cytology instead of histology. In this study,...
Autores principales: | Koomen, Bregje M., van der Starre‐Gaal, Jose, Vonk, Judith M., von der Thüsen, Jan H., van der Meij, Jacqueline J. C., Monkhorst, Kim, Willems, Stefan M., Timens, Wim, ’t Hart, Nils A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246726/ https://www.ncbi.nlm.nih.gov/pubmed/33108706 http://dx.doi.org/10.1002/cncy.22383 |
Ejemplares similares
-
Essential preanalytics in PD‐L1 immunocytochemistry
por: t Hart, Nils A, et al.
Publicado: (2018) -
False‐negative programmed death‐ligand 1 immunostaining in ethanol‐fixed endobronchial ultrasound‐guided transbronchial needle aspiration specimens of non‐small‐cell lung cancer patients
por: Koomen, Bregje M, et al.
Publicado: (2021) -
Automated Immunostaining Platform in Cytology
por: Sharma, Shelly, et al.
Publicado: (2021) -
Nationwide differences in cytology fixation and processing methods and their impact on interlaboratory variation in PD-L1 positivity
por: Koomen, Bregje M., et al.
Publicado: (2022) -
PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation
por: Keppens, Cleo, et al.
Publicado: (2020)